ALLO · Allogene Therapeutics, Inc. · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of ALLO by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 13.97% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 2.11% | 7,325,575 |
| Index ETFs | 11.86% | 41,078,559 |
| Active ETFs | 0.94% | 3,240,061 |
| Active funds | 11.82% | 40,938,316 |
| Unclassified | 0.20% | 682,462 |
| All registered funds | 26.92% | 93,264,973 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding ALLO
175 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 12,142,998 | $25,257,436 | 0.24% | Long | 2026-06-30 | |
| Select Biotechnology Portfolio | FBIOX | 10,044,893 | $20,089,786 | 0.32% | Long | 2026-08-31 | |
| VANGUARD CAPITAL OPPORTUNITY FUND | — | 9,388,170 | $19,527,394 | 0.06% | Long | 2026-06-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 8,666,591 | $18,026,509 | 0.00% | Long | 2026-06-30 | |
| iShares Russell 2000 ETF | IWM | 6,916,407 | $14,386,127 | 0.02% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 3,444,101 | $7,163,730 | 0.06% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 3,223,886 | $6,705,683 | 0.01% | Long | 2026-06-30 | |
| PRIMECAP Odyssey Aggressive Growth Fund | POAGX | 3,475,270 | $6,533,508 | 0.09% | Long | 2026-07-31 | |
| abrdn Life Sciences Investors | HQL | 2,731,752 | $5,682,044 | 0.82% | Long | 2026-06-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 2,909,372 | $5,469,619 | 0.02% | Long | 2026-07-31 | |
| iShares Russell 2000 Value ETF | IWN | 2,479,776 | $5,157,934 | 0.04% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 1,803,716 | $3,751,729 | 0.04% | Long | 2026-06-30 | |
| abrdn Healthcare Investors | HQH | 1,770,000 | $3,681,600 | 0.27% | Long | 2026-06-30 | |
| BlackRock Advantage Small Cap Core Fund | — | 1,764,468 | $3,528,936 | 0.06% | Long | 2026-08-31 | |
| Columbia Small Cap Value Discovery Fund | — | 1,798,280 | $3,380,766 | 0.14% | Long | 2026-07-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 1,521,221 | $3,042,442 | 0.02% | Long | 2026-08-31 | |
| Fidelity Enhanced Small Cap Core ETF | FESM | 1,438,234 | $2,991,527 | 0.05% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 1,419,517 | $2,839,034 | 0.01% | Long | 2026-08-31 | |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | KOMP | 1,314,750 | $2,734,680 | 0.10% | Long | 2026-06-30 | |
| Schwab U.S. Small-Cap ETF | SCHA | 1,318,673 | $2,637,346 | 0.01% | Long | 2026-08-31 | |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND | VSTCX | 1,156,841 | $2,406,229 | 0.08% | Long | 2026-06-30 | |
| Dimensional U.S. Small Cap ETF | DFAS | 1,028,485 | $1,933,552 | 0.01% | Long | 2026-07-31 | |
| VANGUARD U.S. MOMENTUM FACTOR ETF | VFMO | 882,910 | $1,765,820 | 0.09% | Long | 2026-08-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 786,292 | $1,572,584 | 0.01% | Long | 2026-08-31 | |
| Small Cap Value Fund | NOSGX | 631,204 | $1,312,904 | 0.19% | Long | 2026-06-30 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 649,106 | $1,298,212 | 0.02% | Long | 2026-08-31 | |
| U.S. SMALL CAP PORTFOLIO | DFSTX | 665,641 | $1,251,405 | 0.01% | Long | 2026-07-31 | |
| U.S. MICRO CAP PORTFOLIO | DFSCX | 665,494 | $1,251,129 | 0.02% | Long | 2026-07-31 | |
| Schwab Small-Cap Index Fund | SWSSX | 645,365 | $1,213,286 | 0.02% | Long | 2026-07-31 | |
| Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 588,543 | $1,106,461 | 0.04% | Long | 2026-07-31 | |
| Fidelity Total Market Index Fund | FSKAX | 517,328 | $1,034,656 | 0.00% | Long | 2026-08-31 | |
| Master Small Cap Index Series | — | 496,148 | $1,031,988 | 0.02% | Long | 2026-06-30 | |
| iShares U.S. Small-Cap Equity Factor ETF | SMLF | 476,459 | $895,743 | 0.02% | Long | 2026-07-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 431,385 | $862,770 | 0.00% | Long | 2026-08-31 | |
| ALPS Medical Breakthroughs ETF | SBIO | 427,142 | $854,284 | 0.36% | Long | 2026-08-31 | |
| College Retirement Equities Fund - Total Global Stock Account | — | 407,995 | $848,630 | 0.00% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 423,677 | $847,354 | 0.00% | Long | 2026-08-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | LABU | 412,615 | $775,716 | 0.16% | Long | 2026-07-31 | |
| Fidelity Small Cap Value Index Fund | FISVX | 372,025 | $773,812 | 0.04% | Long | 2026-06-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 353,956 | $736,228 | 0.00% | Long | 2026-06-30 | |
| BlackRock Health Sciences Term Trust | BMEZ | 344,966 | $717,529 | 0.07% | Long | 2026-06-30 | |
| Nuveen Small Cap Blend Index Fund | — | 352,649 | $662,980 | 0.02% | Long | 2026-07-31 | |
| NVIT Multi-Manager Small Company Fund | — | 304,265 | $632,871 | 0.14% | Long | 2026-06-30 | |
| JPMorgan Small Cap Value Fund | — | 295,178 | $613,970 | 0.05% | Long | 2026-06-30 | |
| EQ/2000 Managed Volatility Portfolio | — | 288,539 | $600,161 | 0.02% | Long | 2026-06-30 | |
| NVIT Small Cap Value Fund | — | 277,844 | $577,916 | 0.26% | Long | 2026-06-30 | |
| Direxion Moonshot Innovators ETF | — | 207,266 | $572,054 | 2.63% | Long | 2024-04-30 | |
| Ultra-Small Company Market Fund | BRSIX | 250,000 | $520,000 | 0.35% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Portfolio | — | 243,268 | $505,997 | 0.07% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND | — | 251,205 | $502,410 | 0.03% | Long | 2026-08-31 |